Company Filing History:
Years Active: 2009
Title: Paul Hine: Innovator in Rapid Immunoassay Technology
Introduction
Paul Hine is an accomplished inventor based in Holt, MI (US). He has made significant contributions to the field of immunoassay technology, particularly in the rapid detection of anthrax protective antigens. His innovative approach has the potential to enhance the speed and accuracy of bacterial detection in various applications.
Latest Patents
Hine holds a patent for a method titled "Rapid immunoassay of anthrax protective antigen in vaccine cultures and bodily fluids by fluorescence polarization." This inventive subject matter relates to a competitive method for estimating the concentration of proteins or antibodies, specifically protective antigen (PA), lethal factor (LF), and edema factor (EF). The method utilizes Fluorescence Polarization, FLT, or FRET, enabling the detection of target proteins within a rapid timeframe of 5 minutes, across a concentration range of 0.1 to 10.0 nM. This advancement allows for the quick detection and quantification of bacteria, bacterial antigens, or antibodies in culture media or broth.
Career Highlights
Paul Hine is currently associated with the United States Navy, where he contributes his expertise in immunoassay technology. His work is pivotal in advancing methods that can significantly impact public health and safety.
Collaborations
Hine has collaborated with notable colleagues, including Malford E. Cullum and Lloyd Grant Simonson. Their combined efforts have fostered innovation in the field of immunoassays.
Conclusion
Paul Hine's contributions to rapid immunoassay technology exemplify the importance of innovation in addressing critical health challenges. His work not only enhances detection methods but also plays a vital role in ensuring public safety.